Morphine Completed Phase 3 Trials for Pain / Sickle Cell Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01380197Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally
NCT00415597Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain